|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2011-5-17
|
|
pubmed:abstractText |
Overexpression of the oncogen Stathmin has been linked to aggressive endometrial carcinoma and a potential for PI3Kinase inhibitors in this disease. We wanted to validate the prognostic value of Stathmin expression in a large prospective multicenter setting. As lymph node sampling is part of current surgical staging, we also aimed to test if Stathmin expression in endometrial curettage specimens could predict lymph node metastasis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AkslenLars ALA,
pubmed-author:AmantFredericF,
pubmed-author:MarcickiewiczJanuszJ,
pubmed-author:NjolstadTormund STS,
pubmed-author:SalvesenHelga BHB,
pubmed-author:StaffAnne CAC,
pubmed-author:StefanssonIngunn MIM,
pubmed-author:TingulstadSolveigS,
pubmed-author:TrovikJoneJ,
pubmed-author:VandenputIngridI,
pubmed-author:WikElisabethE,
pubmed-author:WudlL RLR
|
|
pubmed:copyrightInfo |
©2011 AACR.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3368-77
|
|
pubmed:meshHeading |
pubmed-meshheading:21242118-Adult,
pubmed-meshheading:21242118-Aged,
pubmed-meshheading:21242118-Aged, 80 and over,
pubmed-meshheading:21242118-Carcinoma,
pubmed-meshheading:21242118-Endometrial Neoplasms,
pubmed-meshheading:21242118-Female,
pubmed-meshheading:21242118-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21242118-Humans,
pubmed-meshheading:21242118-Immunohistochemistry,
pubmed-meshheading:21242118-Lymph Nodes,
pubmed-meshheading:21242118-Lymphatic Metastasis,
pubmed-meshheading:21242118-Middle Aged,
pubmed-meshheading:21242118-Neoplasm Staging,
pubmed-meshheading:21242118-Prognosis,
pubmed-meshheading:21242118-Risk Factors,
pubmed-meshheading:21242118-Stathmin,
pubmed-meshheading:21242118-Survival Analysis,
pubmed-meshheading:21242118-Tumor Markers, Biological,
pubmed-meshheading:21242118-Up-Regulation
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway. jone.trovik@helse-bergen.no
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Evaluation Studies
|
